Consider validity, clinical relevance, and applicability of albumin for critically ill patients.
作者信息
Offringa M
出版信息
BMJ. 1998 Aug 1;317(7154):343. doi: 10.1136/bmj.317.7154.343.
Abstract
摘要
相似文献
1
Consider validity, clinical relevance, and applicability of albumin for critically ill patients.考虑白蛋白对重症患者的有效性、临床相关性和适用性。
BMJ. 1998 Aug 1;317(7154):343. doi: 10.1136/bmj.317.7154.343.
2
Human albumin administration in critically ill patients. Validity of review methods must be assessed.危重症患者使用人白蛋白。必须评估综述方法的有效性。
BMJ. 1998 Sep 26;317(7162):883-4.
3
Human albumin administration in critically ill patients. I would not want an albumin transfusion.危重症患者输注人白蛋白。我不想输注白蛋白。
BMJ. 1998 Sep 26;317(7162):885.
4
Excess mortality after human albumin administration in critically ill patients. Clinical and pathophysiological evidence suggests albumin is harmful.危重症患者输注人白蛋白后的超额死亡率。临床和病理生理学证据表明白蛋白有害。
BMJ. 1998 Jul 25;317(7153):223-4. doi: 10.1136/bmj.317.7153.223.
5
Human albumin administration in critically ill patients. Some patients may benefit.在危重症患者中输注人白蛋白。部分患者可能获益。
BMJ. 1998 Sep 26;317(7162):885-6.
6
Human albumin administration in critically ill patients. Paper failed to mention earlier review.危重症患者使用人白蛋白。该论文未提及早期综述。
BMJ. 1998 Sep 26;317(7162):884.
7
8
9
10
[The pros and cons of albumin infusion in critically ill patients].
Zhonghua Nei Ke Za Zhi. 2012 Nov;51(11):845-7.
引用本文的文献
1
Beyond conflict of interest. What is truth as it relates to albumin?超越利益冲突。与白蛋白相关的真相是什么？
BMJ. 1999 Feb 13;318(7181):464. doi: 10.1136/bmj.318.7181.464a.
本文引用的文献
1
Human albumin administration in critically ill patients: systematic review of randomised controlled trials.危重症患者使用人白蛋白：随机对照试验的系统评价
BMJ. 1998 Jul 25;317(7153):235-40. doi: 10.1136/bmj.317.7153.235.
2
Excess mortality after human albumin administration in critically ill patients. Clinical and pathophysiological evidence suggests albumin is harmful.危重症患者输注人白蛋白后的超额死亡率。临床和病理生理学证据表明白蛋白有害。
BMJ. 1998 Jul 25;317(7153):223-4. doi: 10.1136/bmj.317.7153.223.
Zotero 插件